Developers: | Molli Surgical |
Date of the premiere of the system: | May 2021 |
Branches: | Pharmaceuticals, medicine, healthcare |
2021: Announcement of a system for detecting and removing the "smallest tumors" of the mammary glands
In early May 2021, Molli Surgical introduced the Molli system to detect and remove the "smallest tumors" of the mammary glands. The new technology helps radiologists mark lesions quickly and accurately, and surgeons find and effectively remove small tumor foci, providing the best cosmetic results.
The Molli system consists of an implantable marker, detector and imaging plate. To mark target tissues, radiologists use non-radioactive solid magnets that are introduced into the lesion area on the day of surgery or no more than 30 days before it. During the procedure, the surgeon uses a detector to search for implanted markers, which allows rapid, accurate and effective removal of the tumor focus.
Since the Molli system does not use radioactive, but magnetic tags, hospitals do not have to resort to time-consuming and expensive technologies necessary to comply with radiation safety rules. As a result, the application of the Molli system does not require complex protocols for monitoring and disposal of waste or bulky and expensive equipment. In addition, patients themselves prefer the use of magnets rather than radioactive markers.
The Molli system, the developers note, can also be used in other areas. It is easy to use and designed to work according to clinical standards when using conventional surgical instruments. This technology takes advantage of the easy insertion of the introduser needle and standard marker and is compatible with traditional mammography and ultrasound imaging. Molly's magnetic marker is only 3.2 mm in size, allowing radiologists to accurately localize the smallest non-palpable tumors.[1]